UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Suppression of multiple anti‐apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms

Cancer science, 2022-02, Vol.113 (2), p.597-608

2022

Volltextzugriff (PDF)

FMNL1 promotes proliferation and migration of leukemia cells

Journal of leukocyte biology, 2013-09, Vol.94 (3), p.503-512

2013

Volltextzugriff (PDF)

Autophagy and inflammasome activation are associated with poor response to FLT3 inhibitors in patients with FLT3-ITD acute myeloid leukemia

Scientific reports, 2024-10, Vol.14 (1), p.23882-10, Article 23882

2024

Volltextzugriff (PDF)

Serine peptidase inhibitor Kunitz type 2 (SPINT2) in cancer development and progression

Biomedicine & pharmacotherapy, 2018-05, Vol.101, p.278-286

2018

Volltextzugriff (PDF)

IGF1R/IRS1 targeting has cytotoxic activity and inhibits PI3K/AKT/mTOR and MAPK signaling in acute lymphoblastic leukemia cells

Cancer letters, 2019-08, Vol.456, p.59-68

2019

Volltextzugriff (PDF)

Cellular and Molecular Effects of Eribulin in Preclinical Models of Hematologic Neoplasms

Cancers, 2022-12, Vol.14 (24), p.6080

2022

Volltextzugriff (PDF)

NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells

Scientific reports, 2022-10, Vol.12 (1), p.17092-17092, Article 17092

2022

Volltextzugriff (PDF)

Emerging functions for ANKHD1 in cancer-related signaling pathways and cellular processes

BMB Reports, 2020, 53(8), , pp.413-418

2020

Volltextzugriff (PDF)

Microemulsion for Prolonged Release of Fenretinide in the Mammary Tissue and Prevention of Breast Cancer Development

Molecular pharmaceutics, 2021-09, Vol.18 (9), p.3401-3417

2021

Volltextzugriff (PDF)

Chromomycin A5 induces bona fide immunogenic cell death in melanoma

Frontiers in immunology, 2022-11, Vol.13, p.941757-941757

2022

Volltextzugriff (PDF)

Data mining in acute myeloid leukemia: identification of disease biomarkers, prognostic factors, novel targets, and potential drugs

Translational cancer research, 2023-09, Vol.12 (9), p.2235-2238

2023

Volltextzugriff (PDF)

Pharmacological Inhibition of PIP4K2 Potentiates Venetoclax-Induced Apoptosis in Acute Myeloid Leukemia

International journal of molecular sciences, 2023-12, Vol.24 (23), p.16899

2023

Volltextzugriff (PDF)

Seriniquinones as Therapeutic Leads for Treatment of BRAF and NRAS Mutant Melanomas

Molecules (Basel, Switzerland), 2021-12, Vol.26 (23), p.7362

2021

Volltextzugriff (PDF)

Insulin Substrate Receptor (IRS) proteins in normal and malignant hematopoiesis

Clinics (São Paulo, Brazil), 2018-01, Vol.73 (suppl 1), p.e566s-e566s, Article e566s

2018

Volltextzugriff (PDF)

Stathmin 1 in normal and malignant hematopoiesis

BMB Reports, 2014, 47(12), , pp.660-665

2014

Volltextzugriff (PDF)

Bismuth(III) triflate: an economical and environmentally friendly catalyst for the Nazarov reaction

Beilstein journal of organic chemistry, 2024-05, Vol.20 (1), p.1167-1178

2024

Volltextzugriff (PDF)

Reversine exhibits antineoplastic activity in JAK2V617F-positive myeloproliferative neoplasms

Scientific reports, 2019-07, Vol.9 (1), p.1-9, Article 9895

2019

Volltextzugriff (PDF)

ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells

Experimental cell research, 2014-06, Vol.324 (2), p.137-145

2014

Volltextzugriff (PDF)

IRS1/β‐Catenin Axis Is Activated and Induces MYC Expression in Acute Lymphoblastic Leukemia Cells

Journal of cellular biochemistry, 2017-07, Vol.118 (7), p.1774-1781

2017

Volltextzugriff (PDF)

The Multikinase Inhibitor AD80 Induces Mitotic Catastrophe and Autophagy in Pancreatic Cancer Cells

Cancers, 2023-07, Vol.15 (15), p.3866

2023

Volltextzugriff (PDF)

Up‐regulation of SPINT2/HAI‐2 by Azacytidine in bone marrow mesenchymal stromal cells affects leukemic stem cell survival and adhesion

Journal of cellular and molecular medicine, 2019-02, Vol.23 (2), p.1562-1571

2019

Volltextzugriff (PDF)

Perspectives for Targeting Ezrin in Cancer Development and Progression

Future pharmacology, 2023-03, Vol.3 (1), p.61-79

2023

Volltextzugriff (PDF)

Exploring redox vulnerabilities in JAK2V617F-positive cellular models

Hematology, Transfusion and Cell Therapy, 2021-10, Vol.43 (4), p.430-436

2021

Volltextzugriff (PDF)

Comprehensive analysis of the HCK gene in myeloid neoplasms: Insights into biological functions, prognosis, and response to antineoplastic agents

Hematology, Transfusion and Cell Therapy, 2024-07, Vol.46 (3), p.273-282

2024

Volltextzugriff (PDF)

The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy

Blood cancer journal (New York), 2022-11, Vol.12 (11), p.151-151, Article 151

2022

Volltextzugriff (PDF)

1 – 25 von 185

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(167)
Mit Volltextzugriff
(161)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Suppression of multiple anti‐apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms

FMNL1 promotes proliferation and migration of leukemia cells

Autophagy and inflammasome activation are associated with poor response to FLT3 inhibitors in patients with FLT3-ITD acute myeloid leukemia

Serine peptidase inhibitor Kunitz type 2 (SPINT2) in cancer development and progression

IGF1R/IRS1 targeting has cytotoxic activity and inhibits PI3K/AKT/mTOR and MAPK signaling in acute lymphoblastic leukemia cells

Cellular and Molecular Effects of Eribulin in Preclinical Models of Hematologic Neoplasms

NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells

Emerging functions for ANKHD1 in cancer-related signaling pathways and cellular processes

Microemulsion for Prolonged Release of Fenretinide in the Mammary Tissue and Prevention of Breast Cancer Development

Chromomycin A5 induces bona fide immunogenic cell death in melanoma

Data mining in acute myeloid leukemia: identification of disease biomarkers, prognostic factors, novel targets, and potential drugs

Pharmacological Inhibition of PIP4K2 Potentiates Venetoclax-Induced Apoptosis in Acute Myeloid Leukemia

Seriniquinones as Therapeutic Leads for Treatment of BRAF and NRAS Mutant Melanomas

Insulin Substrate Receptor (IRS) proteins in normal and malignant hematopoiesis

Stathmin 1 in normal and malignant hematopoiesis

Bismuth(III) triflate: an economical and environmentally friendly catalyst for the Nazarov reaction

Reversine exhibits antineoplastic activity in JAK2V617F-positive myeloproliferative neoplasms

ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells

IRS1/β‐Catenin Axis Is Activated and Induces MYC Expression in Acute Lymphoblastic Leukemia Cells

The Multikinase Inhibitor AD80 Induces Mitotic Catastrophe and Autophagy in Pancreatic Cancer Cells

Up‐regulation of SPINT2/HAI‐2 by Azacytidine in bone marrow mesenchymal stromal cells affects leukemic stem cell survival and adhesion

Perspectives for Targeting Ezrin in Cancer Development and Progression

Exploring redox vulnerabilities in JAK2V617F-positive cellular models

Comprehensive analysis of the HCK gene in myeloid neoplasms: Insights into biological functions, prognosis, and response to antineoplastic agents

The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy

Suchergebnisse filtern